10x Genomics (TXG) Other Non-Current Assets (2018 - 2026)

10x Genomics (TXG) has 9 years of Other Non-Current Assets data on file, last reported at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 14.29% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 14.29% YoY), and the FY2025 full-year result was $2.9 million, down 29.45% from the prior year.
• Other Non-Current Assets declined to $2.6 million in Q1 2026, from $2.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $61.0 million in Q4 2023 to a low of $1.9 million in Q3 2025.
• A 5-year average of $7.7 million and a median of $3.2 million in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets soared 306.54% in 2023 and slumped 93.23% in 2024, its largest moves.
• Tracing TXG's Other Non-Current Assets over 5 years: stood at $7.1 million in 2022, then surged by 759.96% to $61.0 million in 2023, then tumbled by 93.23% to $4.1 million in 2024, then fell by 29.45% to $2.9 million in 2025, then slipped by 9.92% to $2.6 million in 2026.
• Business Quant data shows TXG's Other Non-Current Assets at $2.6 million in Q1 2026, $2.9 million in Q4 2025, and $1.9 million in Q3 2025.